(8-098) Design and Methodology of Post-Hoc Analyses to Assess Hospitalizations across the Efsitora QWINT T2D Phase 3 Clinical Trials

Tuesday, December 9, 2025

2:00 PM - 3:30 PM

Location: Bayside A, Level 1

Fellowship Program: Eli Lilly and Company Visiting Scientist Fellowship
Fellowship Location: Indiana

Co-Author(s): Karli Gunn, Esther Levasseur, Kristen Syring, Andrea Goldyn

Primary Author(s)